BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34374310)

  • 1. A single-center experience with giant cell tumors of sphenoid bone and clivus.
    Yaprak Bayrak B; Özcan E; Vural Ç; Emengen A; Çabuk B; Ceylan S
    Tumori; 2021 Dec; 107(6):NP94-NP100. PubMed ID: 34374310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
    Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N
    J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
    Inoue A; Ohnishi T; Kohno S; Nishikawa M; Nishida N; Ohue S
    World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant giant cell tumor of the skull base originating from clivus and sphenoid bone.
    Zorlu F; Selek U; Soylemezoglu F; Oge K
    J Neurooncol; 2006 Jan; 76(2):149-52. PubMed ID: 16205965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.
    Scotto di Carlo F; Divisato G; Iacoangeli M; Esposito T; Gianfrancesco F
    BMC Cancer; 2018 Apr; 18(1):358. PubMed ID: 29609578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab Treatment for a Residual Giant Cell Tumor of the Clivus: A Case Report and Review of the Literature.
    Huh A; Villelli N; Martinez D; Ting J; Birhiray R; Payner TD; Kulwin CG
    World Neurosurg; 2018 Oct; 118():98-101. PubMed ID: 30010069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic endonasal treatment of a large clival giant cell tumor invading the cavernous sinus and temporal lobe.
    Yildirim AE; Divanlioglu D; Cetinalp NE; Ozhamam E; Belen AD
    J Craniofac Surg; 2014 Mar; 25(2):446-8. PubMed ID: 24481168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.
    Freeman JL; Oushy S; Schowinsky J; Sillau S; Youssef AS
    World Neurosurg; 2016 Dec; 96():47-57. PubMed ID: 27269210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.
    Ji T; Yang Y; Wang Y; Sun K; Guo W
    Medicine (Baltimore); 2017 Aug; 96(33):e7799. PubMed ID: 28816971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell tumour of the posterior cranial fossa: a case report.
    Lu ZH; Yao ZW
    Br J Radiol; 2011 Nov; 84(1007):e206-9. PubMed ID: 22011823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical overview of CT and MRI features of developmental, inflammatory, and neoplastic lesions of the sphenoid body and clivus.
    Nardi C; Maraghelli D; Pietragalla M; Scola E; Locatello LG; Maggiore G; Gallo O; Bartolucci M
    Neuroradiology; 2022 Aug; 64(8):1483-1509. PubMed ID: 35657394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant-cell tumor of the sphenoid and temporal bones.
    Glasscock ME; Hunt WE
    Laryngoscope; 1974 Jul; 84(7):1181-7. PubMed ID: 4842779
    [No Abstract]   [Full Text] [Related]  

  • 15. Malignant giant-cell tumor of the parietal bone: case report and review of the literature.
    Leonard J; Gökden M; Kyriakos M; Derdeyn CP; Rich KM
    Neurosurgery; 2001 Feb; 48(2):424-9. PubMed ID: 11220389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.
    Yayan J
    Cancer Control; 2020; 27(3):1073274820934822. PubMed ID: 32869648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresectable Clival Giant Cell Tumor, Tumor Control With Denosumab After Relapse: A Case Report and Systematic Review of the Literature.
    Pionelli MG; Asaftei SD; Tirtei E; Campello A; Di Rosa G; Fagioli F
    J Pediatr Hematol Oncol; 2022 Jul; 44(5):201-209. PubMed ID: 35537059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant cell tumor of bone.
    Eckardt JJ; Grogan TJ
    Clin Orthop Relat Res; 1986 Mar; (204):45-58. PubMed ID: 3514036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Giant cell tumor originating in the sphenoid bone: a case report].
    Kakizawa Y; Tanaka Y; Takasawa H; Oya F; Tada T; Kyoshima K; Kobayashi S
    No Shinkei Geka; 1999 Jul; 27(7):667-72. PubMed ID: 10440042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.
    Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT
    Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.